Tuesday, October 22, 2024
spot_img

Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock

DALLAS, Oct. 21, 2024 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, and its board of directors declared a cash dividend of $14.375 per share of the 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), equivalent to $0.359375 per depositary share, each representing a 1/40th interest in a share of the Series B Preferred Stock. The depositary shares are traded on the NASDAQ under the symbol “TCBIO.” The Series B Preferred Stock dividend is payable on December 16, 2024, to holders of record at the close of business on December 2, 2024.

ABOUT TEXAS CAPITAL BANCSHARES, INC.

Texas Capital Bancshares, Inc. (NASDAQ®: TCBI), a member of the Russell 2000® Index and the S&P MidCap 400®, is the parent company of Texas Capital Bank (“TCB”). Texas Capital is the collective brand name for TCB and its separate, non-bank affiliates and wholly-owned subsidiaries. Texas Capital is a full-service financial services firm that delivers customized solutions to businesses, entrepreneurs and individual customers. Founded in 1998, the institution is headquartered in Dallas with offices in Austin, Houston, San Antonio and Fort Worth, and has built a network of clients across the country. With the ability to service clients through their entire lifecycles, Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities. All services are subject to applicable laws, regulations, and service terms. Deposit and lending products and services are offered by TCB. For deposit products, member FDIC. For more information, please visit www.texascapital.com.

CONTACT: INVESTOR CONTACT
Jocelyn Kukulka, 469.399.8544
[email protected]

MEDIA CONTACT
Julia Monter, 469.399.8425
[email protected]

Powered by SlickText.com

Hot this week

Grupo Aeroportuario del Pacifico Announces Results for the Third Quarter of 2024

GUADALAJARA, Mexico, Oct. 21, 2024 (GLOBE NEWSWIRE)...

Travere Therapeutics to Report Third Quarter 2024 Financial Results

SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE)...

Elcora Proposes to Extend Convertible Promissory Note Maturity Date

HALIFAX, Nova Scotia, Oct. 21, 2024 (GLOBE...

Topics

spot_img

Related Articles

Popular Categories

spot_img